Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Anti-H. pylori cephems in development at Takeda

Nov. 19, 1998

Lamivudine highlighted at recent Study for Liver Diseases meeting

Nov. 18, 1998

Triangle Pharmaceuticals presents preliminary data on FTC in HBV patients

Nov. 18, 1998

Study completed on new therapy for traveler's diarrhea

Nov. 18, 1998

Gilead's adefovir dipivoxil extensively covered at AASLD meeting

Nov. 17, 1998

Pegylated interferon proves superior to standard interferon for treatment of HCV

Nov. 16, 1998

Data presented at AASLD indicate role for caspase inhibitors in liver transplantation

Nov. 16, 1998

Antiulcer tetrahydropyrido compounds in development at Byk Gulden

Nov. 16, 1998

Bristol-Myers Squibb initiates phase III HBV clinical trials; phase II data reported

Nov. 13, 1998

Heptazyme demonstrates potent activity against HCV

Nov. 12, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...